Crolibulin

DB12925InvestigationalSmall molecule

Crolibulin has been used in trials studying the treatment of Solid Tumor and Anaplastic Thyroid Cancer.

Chemical structure of Crolibulin
Mechanism
Curator reviewed
Formula / weight
C18H17BrN4O3 · 417.263 g/mol (avg)
Code names
EPC-2407

Resolves to

Compound
UNII9ENT43KY91CAS1000852-17-4ChEMBLCHEMBL2103852PubChem23649181
Structure
InChIKeyJXONINOYTKKXQQ-CQSZACIVSA-NSMILESCOC1=CC(=CC(Br)=C1OC)[C@@H]1C2=CC=C(N)C(N)=C2OC(N)=C1C#N

What you can answer from here — as of July 07, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
1Clinical trialPhase, status and sponsor resolved per trial
Sign in
4+ReferencesStructured and connected to the statements they support
Sign in

Which companies are running trials of Crolibulin, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In